Heart pump trial aims to boost survival for critical heart failure patients
NCT ID NCT06872021
Summary
This study is testing if adding a small heart pump called an IABP right after a patient is placed on a major life support machine (VA-ECMO) for severe heart failure can improve their chances of survival. It will compare the standard approach to the new approach in 358 critically ill adults across multiple hospitals. The main goal is to see if this early pump use lowers the death rate within 30 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECMO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital
Beijing, Beijing Municipality, 100029, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.